相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-Term Entecavir Treatment Reduces Hepatocellular Carcinoma Incidence in Patients With Hepatitis B Virus Infection
Tetsuya Hosaka et al.
HEPATOLOGY (2013)
Interleukin-22 Promotes Proliferation of Liver Stem/Progenitor Cells in Mice and Patients With Chronic Hepatitis B Virus Infection
Dechun Feng et al.
GASTROENTEROLOGY (2012)
Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice
Fanli Meng et al.
GASTROENTEROLOGY (2012)
Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice
Xiaoni Kong et al.
HEPATOLOGY (2012)
Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B
Corinna Jen-Hui Pan et al.
HEPATOLOGY INTERNATIONAL (2012)
High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B
Shi-Wu Ma et al.
JOURNAL OF HEPATOLOGY (2012)
Rather than interleukin-27, interleukin-6 expresses positive correlation with liver severity in naive hepatitis B infection patients
Jung-Ta Kao et al.
LIVER INTERNATIONAL (2012)
Serum interleukin (IL)-10 and IL-12 levels and IL28B gene polymorphisms: pretreatment prediction of treatment failure in chronic hepatitis C
Takeji Umemura et al.
ANTIVIRAL THERAPY (2011)
A Proinflammatory Role for Interleukin-22 in the Immune Response to Hepatitis B Virus
Ye Zhang et al.
GASTROENTEROLOGY (2011)
Quantitative Hepatitis B Surface Antigen and Hepatitis B e Antigen Titers in Prediction of Treatment Response to Entecavir
Jung Min Lee et al.
HEPATOLOGY (2011)
Interleukin-22 Promotes Human Hepatocellular Carcinoma by Activation of STAT3
Runqiu Jiang et al.
HEPATOLOGY (2011)
Clinical Utility of Hepatitis B Surface Antigen Quantitation in Patients With Chronic Hepatitis B: A Review
Yun-Fan Liaw
HEPATOLOGY (2011)
In Vivo Consequences of Liver-Specific Interleukin-22 Expression in Mice: Implications for Human Liver Disease Progression
Ogyi Park et al.
HEPATOLOGY (2011)
Serum chemokine levels are associated with the outcome of pegylated interferon and ribavirin therapy in patients with chronic hepatitis C
Suguru Yoneda et al.
HEPATOLOGY RESEARCH (2011)
Recent advances in IL-22 biology
Lauren A. Zenewicz et al.
INTERNATIONAL IMMUNOLOGY (2011)
IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B
Jean Publicover et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir
Jurrien G. P. Reijnders et al.
JOURNAL OF HEPATOLOGY (2011)
Induction of CXCR3-and CCR5-associated chemokines during acute hepatitis C virus infection
Marija Zeremski et al.
JOURNAL OF HEPATOLOGY (2011)
Association of Serum Cytokine Levels With Treatment Response to Pegylated Interferon and Ribavirin Therapy in Genotype 1 Chronic Hepatitis C Patients
Suguru Yoneda et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases
Frank Tacke et al.
LIVER INTERNATIONAL (2011)
Serum Levels of Interleukin-10 and Interleukin-12 Predict Early, Spontaneous Hepatitis B Virus e Antigen Seroconversion
Jia-Feng Wu et al.
GASTROENTEROLOGY (2010)
Interleukin-17-Producing CD4(+) T Cells Increase with Severity of Liver Damage in Patients with Chronic Hepatitis B
Ji-Yuan Zhang et al.
HEPATOLOGY (2010)
Interleukin-22 Treatment Ameliorates Alcoholic Liver Injury in a Murine Model of Chronic-Binge Ethanol Feeding: Role off Signal Transducer and Activator of Transcription 3
Sung Hwan Ki et al.
HEPATOLOGY (2010)
A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B
Anthony T. Tan et al.
JOURNAL OF HEPATOLOGY (2010)
Chemokines in the Immunopathogenesis of Hepatitis C Infection
Mathis Heydtmann et al.
HEPATOLOGY (2009)
Interleukin-22-Producing Natural Killer Cells and Lymphoid Tissue Inducer-like Cells in Mucosal Immunity
Marco Colonna
IMMUNITY (2009)
Epidemiology of hepatocellular carcinoma in Japan
Takeji Umemura et al.
JOURNAL OF GASTROENTEROLOGY (2009)
Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan
Takeji Umemura et al.
CLINICAL INFECTIOUS DISEASES (2008)
Intrahepatic Levels of CXCR3-Associated Chemokines Correlate With Liver Inflammation and Fibrosis in Chronic Hepatitis C
Marija Zeremski et al.
HEPATOLOGY (2008)
Interleukin-22 but not interleukin-17 provides protection to Hepatocytes during acute liver inflammation
Lauren A. Zenewicz et al.
IMMUNITY (2007)
Immunoglobin G4-hepatopathy: Association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis
Takeji Umemura et al.
HEPATOLOGY (2007)
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
UH Iloeje et al.
GASTROENTEROLOGY (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Hepatitis B virus DNA-negative Dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domain
T Kimura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Histological outcome during long-term lamivudine therapy
JL Dienstag et al.
GASTROENTEROLOGY (2003)
Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load
T Kimura et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
分享论文
